Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To establish the impact of hysterectomy on sexual function, urethral length and quality of life
The investigators evaluate impact of total hysterectomy (abdominal, by laparoscopy and vaginal) and supracervical hysterectomy (abdominal and by laparoscopy) on quality of life, sexual function, urethral length and urinary incontinence. The patients fulfill questionnaires (UDI 6, IIQ7, FSFI and ICIQ) before operation and 6 months after. Additionally the investigators measure urethral length before procedure and 6 months after.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| TAH | patients before and after total abdominal hysterectomy (TAH) |
| |
| TLH | patients before and after total laparoscopic hysterectomy (TLH) |
| |
| TVH | patients before and after total vaginal hysterectomy (TVH) |
| |
| SAH | patients before and after abdominal supracervical hysterectomy (SAH) |
| |
| SLH | patients before and after supracervical laparoscopic hysterectomy (SLH) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| urethral length measure | Procedure | measure of urethral length, distribution of questionnaires before and after operation |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change from Baseline urethral length at 6 months after hysterectomy | Comparison of urethral length before and after hysterectomy. Urethra will be measured during ultrasound examination in millimeters | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Change from Baseline in sexual functions at 6 months after hysterectomy | The patients fulfill FSFI questionnaire before and after hysterectomy. Range 2-36 with higher scores indicating better sexual function. | 6 months |
| Change from Baseline in appearance of urinary incontinence at 6 months after hysterectomy |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
women who have been qualified to hysterectomy due to fibroids or other benign cndition and who had not undergone any vaginal operation in the past
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Katarzyna A. Skorupska, PhD | Contact | 0048604418512 | kasiaperzylo@hotmail.com | |
| Pawel Miotla, PhD | Contact | 0048604793902 | pmiotla@wp.pl |
| Name | Affiliation | Role |
|---|---|---|
| Tomasz Rechberger, Professor | Medical University of Lublin | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| 2nd Gynecology Department | Recruiting | Lublin | 20-954 | Poland |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007889 | Leiomyoma |
| D014522 | Urethral Diseases |
| D012735 | Sexual Dysfunction, Physiological |
| ID | Term |
|---|---|
| D009379 | Neoplasms, Muscle Tissue |
| D018204 | Neoplasms, Connective and Soft Tissue |
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
|
The patients fulfill UDI 6 (range 0-400) questionnaire to assess appearance of urinary incontinence before and after hysterectomy |
| 6 months |
| Change from Baseline in impact of urinary incontinence at 6 months after hysterectomy | The patients fulfill IIQ 7 (range 0-400) questionnaire to assess impact of hysterectomy on urinary incontinence. | 6 months |
| Change from Baseline in urinary tract symptoms at 6 months after hysterectomy | The patients fulfill ICIQ questionnaire to assess impact of hysterectomy on urinary tract symptoms | 6 months |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D000091662 | Genital Diseases |